Frontlight ResearchEarly access
Trial site
Krasnoyarsk
- 3running trials
The trials here
What the 3 trials at this site are about, from their registry records.
- Conditions
- Metastatic breast cancer2 trials
- Multiple sclerosis1 trial
- Phase
- Phase 31 trial
- Status
- Active, not recruiting3 trials
- Lead sponsor
- Novartis Pharmaceuticals3 trials
Running trials
Active, not recruiting
Active, not recruiting
Active, not recruiting
Long-term Safety, Tolerability and Effectiveness Study of Ofatumumab in Patients With Relapsing MS
Site data: ClinicalTrials.govUpdated 12 Nov 2026